VJHemOnc is committed to improving our service to you

EHA 2019 | DEFIFRANCE: real world defibrotide data for VOD/SOS after HSCT

VJHemOnc is committed to improving our service to you

Mohamad Mohty

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, gives us the latest interim results of the DEFIFRANCE study, which investigated defribrotide in adults with veno-occlusive disease (VOD) / sinusoidal obstruction syndrome (SOS) after HSCT. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter